{
  "catalogId": "7cc6e36c-1a99-4bba-85f0-7156921b5793",
  "name": "EXONDYS 51",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "160 85 35258 00",
  "treatmentDescriptions": "EXONDYS 51 is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping.",
  "termsOfIssue": "Prescription required",
  "form": "concentrate for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ETEPLIRSEN/",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "M09AX06",
      "name": "ETEPLIRSEN"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "EXONDYS 51\t 1VIAL  100 MG/2ML",
      "manufacturer": {
        "name": "תרומד",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 2.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "30",
      "storageConditions": "",
      "codes": {
        "moh": "8237"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": "",
        "retailMargin": "",
        "maxRetailPrice": "",
        "maxPriceWithVAT": ""
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:12.661793"
  }
}